Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association

Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association

Transition from Pediatric to Adult Health Care

Genetic Testing in Youth with High Cholesterol

S1E1: Clinical Pearls on Provider Methods for Obtaining Prior Authorizations for PCSK9i

Join Dr. Alan Brown and Dr. Kim Birtcher as they discuss the complexities of prior authorizations and what methods providers can utilize to obtain prior…

Postprandial Dysmetabolism: Understanding the Impact of Elevated Postprandial Glucose and Triglycerides with the Potential to Prevent or Intervene Early

In 2019, the Centers for Disease Control and Prevention reported that prevalence for both obesity and overweight have continued to rise over the last eight…

Women’s Health: Guidelines for Lipid-Lowering in Women – What Have we Learned?

Cardiovascular disease (CVD) remains the leading cause of death for women in the United States.(1) Unique factors affecting a woman’s health contribute significantly to CVD risk, but historically were not always represented in major guidelines….

Lipid Metabolism and Cardiovascular Disease in Patients with Renal Disease

Reduced estimated glomerular filtration rate (GFR) and chronic kidney disease (CKD) are also independently associated with the risk of death and cardiovascular (CV) events in community.(3) When compared to the general population, patients with CKD…

Elevated LDL Secondary to Multiple Myeloma

Introduction Elevated cholesterol is a well-known and modifiable risk factor for cardiovascular disease. Hyperlipidemia due to secondary causes is common and should be evaluated as part of treatment. Potential secondary causes include diabetes mellitus, excessive…